Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ALLR ALLARITY THERAPEUTICS INC

Watchlist
1.300
-0.020-1.52%
Close 07/01 16:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
1.320
Open
1.310
Turnover
77.06K
Low
1.250
Pre Close
1.320
Volume
60.07K
Market Cap
12.07M
P/E(TTM)
Loss
52wk High
18.200
Shares
9.28M
P/E(Static)
Loss
52wk Low
1.100
Float Cap
9.67M
Bid/Ask %
-33.33%
Historical High
18.200
Shs Float
7.44M
Volume Ratio
0.74
Historical Low
1.100
Dividend TTM
--
Div Yield TTM
--
P/B
0.82
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.81%
Amplitude
5.30%
Avg Price
1.282
Lot Size
1
Float Cap
9.67M
Bid/Ask %
-33.33%
Historical High
18.200
Shs Float
7.44M
Volume Ratio
0.74
Historical Low
1.100
Dividend TTM
--
P/B
0.82
Dividend LFY
--
Turnover Ratio
0.81%
Amplitude
5.30%
Avg Price
1.282
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
CEO: Carchedi, Stefano R.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top